Skip to content

Clinical trials

Terminated Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Status: Terminated Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20092
20102
20113
20123
20134
20144
20154
20163
20175
20187
20197
20205
20214
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)4
Hoffmann-La Roche3
Massachusetts General Hospital3
Institut de Recherches Internationales Servier2
Seaside Therapeutics, Inc.2
Stanford University2
University of Arkansas2
University of Nebraska2
Yale University2
Arizona State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder60
Autistic Disorder23
Child Development Disorders, Pervasive5
Attention Deficit Disorder with Hyperactivity4
Asperger Syndrome3
Bipolar Disorder2
Epilepsy2
Sleep Wake Disorders2
Acquired Immunodeficiency Syndrome1
Anemia, Sickle Cell1

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.